Showing 1 posts of 1 posts found.
inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement